The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.
The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.
“We know exactly where to fight this new virus,” University of Pittsburgh School of Medicine said.
Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.
Coronavirus News Roundup: FDA Emergency Use Authorizations, Vaccine Candidate, and Virtual Blood Drives
Here's a roundup of the latest coronavirus-related news.
Concerns about adequate protection from COVID-19 have led to several efforts from chain pharmacies to keep pharmacy staff and employees safe.
Johnson & Johnson expects to initiate human clinical studies for its lead COVID-19 vaccine candidate by September 2020.
Chloroquine and hydroxychloroquine have been authorized to treat hospitalized patients with COVID-19.
Abbott’s ID NOW COVID-19 test is able to deliver results in as little as 5 minutes.
Here’s a roundup of the latest coronavirus-related news from this week.